Aprea Therapeutics, Inc.

APRE · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 8 employees
145
SEC Filings
$0.5323
Close 2026-10-19
8
Employees

Business Summary

Aprea Therapeutics is a clinical-stage precision medicine oncology company developing small molecule inhibitors that exploit synthetic lethality in cancer cells with specific genetic mutations. Its lead programs include APR-1051 (WEE1 inhibitor) in Phase 1 trials, ATRN-119 (ATR inhibitor) with determined RP2D, and APR-1602 (DYRK1A/B inhibitor) in preclinical development. The company targets biomarker-defined cancers, focusing on DNA damage response pathways to selectively kill cancer cells while sparing healthy tissue.

Latest Stock Quote

APRE 2026-10-19 $0.5323 O:$0.603 H:$0.6053 L:$0.5296 Vol:0.2M VWAP:$0.5541
origin leaf: null

Next Earnings

expected 2027-02-03

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001104659-26-028068EDGAR95K words
2025-03-252024-12-310001558370-25-003588EDGAR93K words
2024-03-262023-12-310001558370-24-003886EDGAR96K words
2023-03-302022-12-310001558370-23-005126EDGAR92K words
2022-03-152021-12-310001558370-22-003671EDGAR99K words
2021-03-162020-12-310001558370-21-003083EDGAR104K words
2020-03-272019-12-310001558370-20-003257EDGAR103K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-042026-09-300001104659-26-122405EDGAR62K words
2026-08-122026-06-300001104659-26-094544EDGAR61K words
2025-11-122025-09-300001104659-25-109867EDGAR61K words
2025-08-122025-06-300001558370-25-011152EDGAR60K words
2025-05-142025-03-310001558370-25-007667EDGAR59K words
2024-11-072024-09-300001558370-24-014767EDGAR61K words
2024-08-122024-06-300001558370-24-011806EDGAR60K words
2024-05-142024-03-310001558370-24-008069EDGAR59K words
2023-11-092023-09-300001558370-23-018572EDGAR62K words
2023-08-102023-06-300001558370-23-014405EDGAR63K words
2023-05-152023-03-310001558370-23-009887EDGAR61K words
2022-11-092022-09-300001558370-22-017205EDGAR65K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-040001104659-26-122403EDGAR3K words
2026-08-280001104659-26-102795EDGAR1K words
2026-08-120001104659-26-094542EDGAR3K words
2026-07-230001104659-26-086254EDGAR1K words
2026-04-010001104659-26-038258EDGAR1K words
2026-03-300001104659-26-036821EDGAR4K words
2026-03-160001104659-26-028046EDGAR3K words
2026-02-180001104659-26-016797EDGAR1K words
2026-01-290001104659-26-007988EDGAR4K words
2026-01-230001104659-26-006267EDGAR1K words

145 total filings indexed. 116 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

precision-oncology biomarker-defined-cancers dna-damage-response-(ddr)-therapeutics synthetic-lethality-based-cancer-therapeutics advanced-solid-tumors recist-v1.1-criteria pcwg3-criteria

Company Identity

CIK0001781983
TickerAPRE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.aprea.com
Listed2019-10-03

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: f7afb88792225d93113895f3a1ede9894d8359f5d0c797210c57c3abdfa59397
parent: c5f27d7326cc2d84426ef0bde3bb8a5f7d7532a39051cbea4344b52526a47c9e
content hash: 8c47b7390b812c37e731b831ea2ad07aa6b30538cf9540c2362b4f6b8fac4b6d
signed: 2026-11-16T19:00:39.538Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up APRE using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on APRE, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/APRE (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.